Stockreport

CohBar Provides Update on CB4211 Phase 1b Study for NASH and Obesity

CohBar, Inc.  (CWBR) 
NASDAQ:AMEX Investor Relations: ir.cohbar.com
PDF MENLO PARK, Calif., March 30, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics t [Read more]